FDA PREPARING GUIDANCE AIMED AT STANDARDIZING FDA/INDUSTRY INTERACTIONS
This article was originally published in The Tan Sheet
Executive Summary
FDA PREPARING GUIDANCE AIMED AT STANDARDIZING FDA/INDUSTRY INTERACTIONS as part of the agency's Good Review Practices initiative, Center for Drug Evaluation & Research Director Janet Woodcock, MD, said in a June 28 briefing with trade press. Woodcock assumed the center director position at the end of May.